New York investigation may distract, cost UnitedHealth

A day after New York's attorney general took aim at UnitedHealth Group's healthcare reimbursement procedures, the ultimate financial implications for the nation's largest insurer were yet to come into focus. But there is little doubt that Andrew Cuomo's probe has handed company executives a significant distraction and a bit of a black eye. Although some analysts believe UnitedHealth will continue to operate with minimal bottom-line effect during Cuomo's fledgling inquiry and expected lawsuit, the consensus is far from unanimous.